Clinical Development Gene Silencing Marketing Pharma Companies 
pharmaphorum
DECEMBER 23, 2020
The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade. Biogen and Denali will co-market the lead LRRK2 product in the US and China, and Biogen will commercialise in all other markets.
Drug Discovery World
OCTOBER 4, 2022
Cell and gene therapies. There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . With 3,633 advanced therapeutical medicinal products (ATMPs) currently in some form of clinical or pre- clinical development, the sector shows no signs of slowing down.
Expert insights. Personalized for you.
86 
Let's personalize your content